These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 7518802

  • 1. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
    Maloy KJ, Donachie AM, O'Hagan DT, Mowat AM.
    Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
    [Abstract] [Full Text] [Related]

  • 2. Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens.
    Mowat AM, Maloy KJ, Donachie AM.
    Immunology; 1993 Dec; 80(4):527-34. PubMed ID: 7508416
    [Abstract] [Full Text] [Related]

  • 3. Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS.
    Maloy KJ, Donachie AM, Mowat AM.
    Eur J Immunol; 1995 Oct; 25(10):2835-41. PubMed ID: 7589080
    [Abstract] [Full Text] [Related]

  • 4. Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-gamma.
    Smith RE, Donachie AM, McLaren FH, Mowat AM.
    Immunology; 1998 Apr; 93(4):556-62. PubMed ID: 9659229
    [Abstract] [Full Text] [Related]

  • 5. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.
    O'Hagan DT, Jeffery H, Davis SS.
    Vaccine; 1993 Apr; 11(9):965-9. PubMed ID: 8212845
    [Abstract] [Full Text] [Related]

  • 6. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.
    Challacombe SJ, Rahman D, Jeffery H, Davis SS, O'Hagan DT.
    Immunology; 1992 May; 76(1):164-8. PubMed ID: 1628895
    [Abstract] [Full Text] [Related]

  • 7. Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route.
    Mowat AM, Donachie AM, Reid G, Jarrett O.
    Immunology; 1991 Mar; 72(3):317-22. PubMed ID: 2026440
    [Abstract] [Full Text] [Related]

  • 8. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
    Lavelle EC, Yeh MK, Coombes AG, Davis SS.
    Vaccine; 1999 Feb 12; 17(6):512-29. PubMed ID: 10075157
    [Abstract] [Full Text] [Related]

  • 9. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
    Porgador A, Staats HF, Faiola B, Gilboa E, Palker TJ.
    J Immunol; 1997 Jan 15; 158(2):834-41. PubMed ID: 8993001
    [Abstract] [Full Text] [Related]

  • 10. Biodegradable microparticles as controlled release antigen delivery systems.
    O'Hagan DT, Rahman D, McGee JP, Jeffery H, Davies MC, Williams P, Davis SS, Challacombe SJ.
    Immunology; 1991 Jun 15; 73(2):239-42. PubMed ID: 2071168
    [Abstract] [Full Text] [Related]

  • 11. CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen.
    Mowat AM, Donachie AM, Jägewall S, Schön K, Löwenadler B, Dalsgaard K, Kaastrup P, Lycke N.
    J Immunol; 2001 Sep 15; 167(6):3398-405. PubMed ID: 11544331
    [Abstract] [Full Text] [Related]

  • 12. Induction of systemic and mucosal immune responses following immunization with somatostatin-avidin complexes incorporated into ISCOMS.
    Estrada A, Laarveld B, Li B, Redmond MJ.
    Immunol Invest; 1995 Aug 15; 24(5):819-28. PubMed ID: 8543345
    [Abstract] [Full Text] [Related]

  • 13. Oral administration of bovine whey proteins to mice elicits opposing immunoregulatory responses and is adjuvant dependent.
    Afuwape AO, Turner MW, Strobel S.
    Clin Exp Immunol; 2004 Apr 15; 136(1):40-8. PubMed ID: 15030512
    [Abstract] [Full Text] [Related]

  • 14. The role of antigen-presenting cells and interleukin-12 in the priming of antigen-specific CD4+ T cells by immune stimulating complexes.
    Robson NC, Beacock-Sharp H, Donachie AM, Mowat AM.
    Immunology; 2003 Sep 15; 110(1):95-104. PubMed ID: 12941146
    [Abstract] [Full Text] [Related]

  • 15. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
    Cibulski SP, Mourglia-Ettlin G, Teixeira TF, Quirici L, Roehe PM, Ferreira F, Silveira F.
    Vaccine; 2016 Feb 24; 34(9):1162-71. PubMed ID: 26826546
    [Abstract] [Full Text] [Related]

  • 16. Controlled release microparticles for vaccine development.
    O'Hagan DT, Jeffery H, Roberts MJ, McGee JP, Davis SS.
    Vaccine; 1991 Oct 24; 9(10):768-71. PubMed ID: 1759495
    [Abstract] [Full Text] [Related]

  • 17. Immunization by particle bombardment of antigen-loaded poly-(DL-lactide-co-glycolide) microspheres in mice.
    Uchida M, Natsume H, Kishino T, Seki T, Ogihara M, Juni K, Kimura M, Morimoto Y.
    Vaccine; 2006 Mar 15; 24(12):2120-30. PubMed ID: 16356602
    [Abstract] [Full Text] [Related]

  • 18. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
    Kunisawa J, Takahashi I, Okudaira A, Hiroi T, Katayama K, Ariyama T, Tsutsumi Y, Nakagawa S, Kiyono H, Mayumi T.
    Eur J Immunol; 2002 Aug 15; 32(8):2347-55. PubMed ID: 12209648
    [Abstract] [Full Text] [Related]

  • 19. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.
    Bowen JC, Nair SK, Reddy R, Rouse BT.
    Immunology; 1994 Mar 15; 81(3):338-42. PubMed ID: 8206507
    [Abstract] [Full Text] [Related]

  • 20. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
    Mohanan D, Gander B, Kündig TM, Johansen P.
    Eur J Pharm Biopharm; 2012 Feb 15; 80(2):274-81. PubMed ID: 22024408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.